ReachMD

Be part of the knowledge.™

CME/CE

Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, women's health and more. And our CME library is continuously growing, every quarter.

1355

LikeLikedUnlike

Episodes 196-210 of 861

KOL Knockout™: Endocrinology Edition – Thyroid Titans Clash to Enhance Outcomes in Thyroid Eye Disease Round 1
CME/CE Broadcast Replay
KOL Knockout™: Endocrinology Edition – Thyroid Titans Clash to Enhance Outcomes in Thyroid Eye Disease Round 1
- Malini Gupta, MD, ECNU, FACE
  Peer
- Alireza Falahati, MD, FACE
  Peer
- Anupam Kotwal, MD, MSc, FACE, FRCP (Edin)
  Peer
- Rokshana R. Thanadar, MD, FACE, FEAA
  Peer
1.25 credits
Selecting Anticoagulants for Acute VTE
MinuteCE®
Selecting Anticoagulants for Acute VTE
- Geoffrey Barnes, MD, MSc
  Peer
1.00 program credits
Case: Anticoagulation Considerations for Atrial Fibrillation
MinuteCE®
Case: Anticoagulation Considerations for Atrial Fibrillation
- Steve Deitelzweig, MD, MMM, SFHM, FACP, FACC
  Peer
1.25 program credits
Identifying Patients at Risk for VTE
MinuteCE®
Identifying Patients at Risk for VTE
- Geoffrey Barnes, MD, MSc
  Peer
1.00 program credits
Case: Approaches to Anticoagulation for Atrial Fibrillation
MinuteCE®
Case: Approaches to Anticoagulation for Atrial Fibrillation
- Christopher B. Granger, MD
  Peer
1.25 program credits
Cervical Cancer: HER2-Targeted ADCs – Current Status and Future Directions
MinuteCE®
Cervical Cancer: HER2-Targeted ADCs – Current Status and Future Directions
- Kathleen Moore, MD, MS
  Peer
1.00 program credits
The Gut Microbiome: An Evidence-Based Approach to Managing Recurrent C difficile Infection
CME/CE
The Gut Microbiome: An Evidence-Based Approach to Managing Recurrent C difficile Infection
- Colleen Kelly
  Peer
- Andrea Banty, DNP, FNP
  Peer
0.75 credits
Addressing the Unmet Need in HER2-Positive Advanced Solid Tumors: Exploring Response Rates and Duration of Response
MinuteCE®
Addressing the Unmet Need in HER2-Positive Advanced Solid Tumors: Exploring Response Rates and Duration of Response
- Susana Banerjee, MBBS, MA, FRCP, PhD
  Peer
1.00 program credits
ASCO/ESMO 2023 Roundtable: Contextualizing the Latest Advances in HER2-Targeted Therapy for Solid Tumors
MinuteCE®
ASCO/ESMO 2023 Roundtable: Contextualizing the Latest Advances in HER2-Targeted Therapy for Solid Tumors
- Kathleen Moore, MD, MS
  Peer
- Susana Banerjee, MBBS, MA, FRCP, PhD
  Peer
- Shubham Pant, MD, MBBS
  Peer
1.00 program credits
Ovarian Cancer: Advances in HER2-Targeted ADCs
MinuteCE®
Ovarian Cancer: Advances in HER2-Targeted ADCs
- Kathleen Moore, MD, MS
  Peer
1.00 program credits
Management Strategies for Treatment-Emergent Adverse Events (TEAEs) in HER2-Altered Advanced Solid Tumors
MinuteCE®
Management Strategies for Treatment-Emergent Adverse Events (TEAEs) in HER2-Altered Advanced Solid Tumors
- Kathleen Moore, MD, MS
  Peer
- Brad McGregor, MD
  Peer
1.00 program credits
Biliary Tract and Pancreatic Cancer: HER2-Targeted ADCs for Gastrointestinal Cancers
MinuteCE®
Biliary Tract and Pancreatic Cancer: HER2-Targeted ADCs for Gastrointestinal Cancers
- Shubham Pant, MD, MBBS
  Peer
1.00 program credits
Maximizing Benefit with the Expanding Options for Gastric Cancer: Patient Selection and Management
CME/CE
Maximizing Benefit with the Expanding Options for Gastric Cancer: Patient Selection and Management
- James M. Cleary, MD, PhD
  Peer
- Kathleen Madden, FNP, MSN, AOCNP, APHN
  Peer
1.00 credits
Endometrial Cancer: HER2-Targeted ADCs: A Promising Approach to Address Unmet Needs
MinuteCE®
Endometrial Cancer: HER2-Targeted ADCs: A Promising Approach to Address Unmet Needs
- Kathleen Moore, MD, MS
  Peer
1.00 program credits
MinuteCE®
Targeting HER2 Across Advanced Solid Tumors
- Susana Banerjee, MBBS, MA, FRCP, PhD
  Peer
- Brad McGregor, MD
  Peer
- Kathleen Moore, MD, MS
  Peer
- Shubham Pant, MD, MBBS
  Peer
1.00 credits 10 episodes

Program Chapters

Segment Chapters

Playlist:

Recommended